p.112 抽出テキスト

lines for performance of transesophageal echocardiography in the patient with pediatric acquired or congenital heart disease: report from the task force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 2005; 18: 91-98. PMID: 15637497 173. Bonnichsen C, Ammash N. Choosing Between MRI and CT Imaging in the Adult with Congenital Heart Disease. Curr Cardiol Rep 2016; 18: 45. PMID: 27002621 174. 日本腎臓学会,日本医学放射線学会,日本循環器学会.腎障害患者におけるヨード造影剤使用に関するガイドライン2018.東京医学社 2018. 175. Han BK, Rigsby CK, Leipsic J, et al. Computed Tomography Imaging in Patients with Congenital Heart Disease, Part 2: Technical Recommendations. An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT): Endorsed by the Society of Pediatric Radiology (SPR) and the North American Society of Cardiac Imaging (NASCI). J Cardiovasc Comput Tomogr 2015; 9: 493-513. PMID: 26679548 176. Schievano S, Capelli C, Young C, et al. Four-dimensional computed tomography: a method of assessing right ventricular outflow tract and pulmonary artery deformations throughout the cardiac cycle. Eur Radiol 2011; 21: 36-45. PMID: 20680286 177. Fratz S, Chung T, Greil GF, et al. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson 2013; 15: 51. PMID: 23763839 178. 日本医学放射線学会,日本腎臓学会.腎障害患者におけるガドリニウム造影剤使用に関するガイドライン 第2版.2009. 179. Ohuchi H, Miyazaki A, Negishi J, et al. Hemodynamic determinants of mortality after Fontan operation. Am Heart J 2017; 189: 9-18. PMID: 28625386 180. 日本循環器学会.先天性心疾患並びに小児期心疾患の診断検査と薬物療法ガイドライン(2018年改訂版).https://www.j-circ. or.jp/cms/wp-content/uploads/2020/02/JCS2018_Yasukochi.pdf 181. van Riel AC, Schuuring MJ, van Hessen ID, et al. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification. Int J Cardiol 2014; 174: 299-305. PMID: 24794056 182. 日本循環器学会.肺高血圧症治療ガイドライン(2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2017/10/JCS2017_ fukuda_h.pdf 183. Kijima Y, Akagi T, Takaya Y, et al. Treat and repair strategy in patients with atrial septal defect and significant pulmonary arterial hypertension. Circ J 2016; 80: 227-234. PMID: 26567484 184. Akagi S, Kasahara S, Sarashina T, et al. Treat-and-repair strategy is a feasible therapeutic choice in adult patients with severe pulmonary arterial hypertension associated with a ventricular septal defect: case series. Eur Heart J Case Rep 2018; 2: 1-7. PMID: 31020114 185. Bonnet D, Bonhoeffer P, Piéchaud JF, et al. Long-term fate of the coronary arteries after the arterial switch operation in newborns with transposition of the great arteries. Heart 1996; 76: 274-279. PMID: 8868989 186. Hernández-Madrid A, Paul T, Abrams D, et al. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace 2018; 20: 1719-1753. PMID: 29579186 187. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008; 358: 2148-2159. PMID: 18480207 188. Chow PC, Cheung EW, Chong CY, et al. Brain natriuretic peptide as a biomarker of systemic right ventricular function in patients with transposition of great arteries after atrial switch operation. Int J Cardiol 2008; 127: 192-197. PMID: 17643533 189. Norozi K, Buchhorn R, Alpers V, et al. Relation of systemic ventricular function quantified by myocardial performance index (Tei) to cardiopulmonary exercise capacity in adults after Mustard procedure for transposition of the great arteries. Am J Cardiol 2005; 96: 1721-1725. PMID: 16360364 190. Schaefer A, Tallone EM, Westhoff-Bleck M, et al. Relation of diastolic and systolic function, exercise capacity and brain natriuretic peptide in adults after Mustard procedure for transposition of the great arteries. Cardiology 2010; 117: 112-117. PMID: 20962526 191. Koch AM, Zink S, Singer H. B-type natriuretic peptide in patients with systemic right ventricle. Cardiology 2008; 110: 1-7. PMID: 17934262 192. Larsson DA, Meurling CJ, Holmqvist F, et al. The diagnostic and

prognostic value of brain natriuretic peptides in adults with a sys- temic morphologically right ventricle or Fontan-type circulation. Int J Cardiol 2007; 114: 345-351. PMID: 16777247 193. Trojnarska O, Gwizdała A, Katarzyński S, et al. Evaluation of exer-

cise capacity with cardiopulmonary exercise testing and BNP levels in adult patients with single or systemic right ventricles. Arch Med Sci 2010; 6: 192-197. PMID: 22371746 194. Garg R, Raman SV, Hoffman TM, et al. Serum markers of systemic right ventricular function and exercise performance. Pediatr Cardiol 2008; 29: 641-648. PMID: 18185948 195. Winter MM, Bouma BJ, van Dijk AP, et al. Relation of physical activity, cardiac function, exercise capacity, and quality of life in patients with a systemic right ventricle. Am J Cardiol 2008; 102: 1258-1262. PMID: 18940303 196. Plymen CM, Hughes ML, Picaut N, et al. The relationship of systemic right ventricular function to ECG parameters and NT-proBNP levels in adults with transposition of the great arteries late after Senning or Mustard surgery. Heart 2010; 96: 1569-1573. PMID: 20720248 197. Szymański P, Klisiewicz A, Lubiszewska B, et al. Gender differences in angiotensin II and aldosterone secretion in patients with pressure overloaded systemic right ventricles are similar to those observed in systemic arterial hypertension. Int J Cardiol 2011; 147: 366-370. PMID: 19896738 198. Dore A, Houde C, Chan KL, et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: A multicenter, randomized, placebo-controlled clinical trial. Circulation 2005; 112: 2411-2416. PMID: 16216961 199. Nagaya N, Nishikimi T, Uematsu M, et al. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J 1998; 136: 297-301. PMID: 9704693 200. Norozi K, Buchhorn R, Kaiser C, et al. Plasma N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair. Chest 2005; 128: 2563-2570. PMID: 16236924 201. Norozi K, Buchhorn R, Bartmus D, et al. Elevated brain natriuretic peptide and reduced exercise capacity in adult patients operated on for tetralogy of fallot is due to biventricular dysfunction as determined by the myocardial performance index. Am J Cardiol 2006; 97: 1377-1382. PMID: 16635615 202. Festa P, Ait-Ali L, Prontera C, et al. Amino-terminal fragment of pro-brain natriuretic hormone identifies functional impairment and right ventricular overload in operated tetralogy of Fallot patients. Pediatr Cardiol 2007; 28: 339-345. PMID: 17607499 203. Giannakoulas G, Mouratoglou SA, Gatzoulis MA, et al. Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. A systematic review. Int J Cardiol 2014; 174: 618-623. PMID: 24814894 204. Koch AM, Zink S, Glöckler M, et al. Plasma levels of B-type natriuretic peptide in patients with tetralogy of Fallot after surgical repair. Int J Cardiol 2010; 143: 130-134. PMID: 19232757 205. Oosterhof T, Tulevski II, Vliegen HW, et al. Effects of volume and/ or pressure overload secondary to congenital heart disease (tetralogy of fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels. Am J Cardiol 2006; 97: 1051-1055. PMID: 16563914 206. Westhoff-Bleck M, Girke S, Breymann T, et al. Pulmonary valve replacement in chronic pulmonary regurgitation in adults with congenital heart disease: Impact of preoperative QRS-duration and NT-proBNP levels on postoperative right ventricular function. Int J Cardiol 2011; 151: 303-306. PMID: 20598759 207. Nagaya N, Nishikimi T, Uematsu M, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000; 102: 865-870. PMID: 10952954 208. Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31: 202-208. PMID: 9426041 209. Madamanchi C, Alhosaini H, Sumida A, et al. Obesity and natriuretic peptides, BNP and NT-proBNP: Mechanisms and diagnostic implications for heart failure. Int J Cardiol 2014; 176: 611-617. PMID: 25156856 210. Panagopoulou V, Deftereos S, Kossyvakis C, et al. NTproBNP: An important biomarker in cardiac diseases. Curr Top Med Chem 2013; 13: 82-94. PMID: 23470072 211. Eindhoven JA, Roos-Hesselink JW, van den Bosch AE, et al. High-sensitive troponin-T in adult congenital heart disease. Int J Cardiol 2015; 184: 405-411. PMID: 25746495 212. Abiko M, Inai K, Shimada E, et al. The prognostic value of high

sensitivity cardiac troponin T in patients with congenital heart dis-